BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250127
DTEND;VALUE=DATE:20250130
DTSTAMP:20260515T121520
CREATED:20241114T140137Z
LAST-MODIFIED:20241114T140346Z
UID:40094-1737936000-1738195199@www.pharmajournalist.com
SUMMARY:The 3rd Medical Device Software Development Summit Europe
DESCRIPTION:Integrating Expertise from Software Development\, Quality Assurance\, Regulatory Affairs\, & Product Teams to Drive Innovation in Alignment with Global Regulatory Guidelines\, AI & ML Enabled Software\, Cybersecurity\, & Agile Methodologies: \nThe European market is capturing 30% of the global medical device field driven by rapid advances in innovative software\, AI\, and ML. But as medical device developers are met with tedious submission processes\, ever-changing software patches\, and red tape at every turn\, it has never been more important to break out of cross-functional silos and stay two steps ahead of compliance guidelines. \nDedicated to unravelling a matrix of multi-layered European and global regulations\, mitigating vulnerabilities in security\, and managing updates to legacy devices\, the 3rd Medical Device Software Development Summit Europe is uniting medical device giants and innovative start-ups to share case studies and best practices in advancing and maintaining compliance of innovative software. \nReturning to Munich in January\, this Summit will be shining the spotlight on: \n\nWorking strategies shown through examples of documentation for AI enabled medical device software\nImplementing automation tools to establish feedback loops throughout the software development process\nImplementing rigorous data validation and cleansing processes to ensure reliability of training datasets for AI models\nCreating synergy between business and engineering through a unified data strategy\n\nUniquely positioned to share strategic guidance in optimising efficiency in regulatory submissions\, streamlining development processes\, and embedding compliant AI and ML in medical devices\, join 70+ CTOs\, Heads of Software\, Product\, RA\, and QA to harmonise cross-functional objectives\, accelerate time to market\, and optimise updates to legacy devices. \nCurious to find out more? Download the Agenda here: https://ter.li/5y1i73
URL:http://www.pharmajournalist.com/event/the-3rd-medical-device-software-development-summit-europe/
LOCATION:H4 Hotel Munchen Messe\, Konrad-Zuse-Platz 14\, Munchen\, 81829\, Germany
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250131
DTSTAMP:20260515T121520
CREATED:20241008T141023Z
LAST-MODIFIED:20241008T141023Z
UID:39875-1738022400-1738281599@www.pharmajournalist.com
SUMMARY:4th mRNA-Based Therapeutics Summit Europe
DESCRIPTION:The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt\, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets\, never-before-seen pre-clinical and clinical data\, and demonstrating key routes to commercial success for mRNA therapy and vaccine R&D pipelines. \nWhether you’re entering the mRNA arena for the first time or a well-seasoned mRNA veteran\, with two dedicated tracks of content spanning discovery through commercialisation\, this forum will equip you with the know-how and connections to make rapid advances in your work with partnering and collaborative networking opportunities spread throughout. \nAssembling 200+ mRNA enthusiasts from across Europe\, Asia and the globe\, this is your one-stop-shop to gain unparalleled overview of cutting-edge R&D innovations\, whilst diving deep into end-to-end development strategy to revolutionise the next wave of mRNA medicines towards clinical reality. \nDownload the event guide for full details: https://ter.li/qd1z5z
URL:http://www.pharmajournalist.com/event/4th-mrna-based-therapeutics-summit-europe/
LOCATION:Sheraton Frankfurt Airport Hotel & Conference Center\, Hugo-Eckener-Ring 15/Terminal 1\, Frankfurt am Main\, 60549\, Germany
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250131
DTSTAMP:20260515T121520
CREATED:20241008T142442Z
LAST-MODIFIED:20241008T144847Z
UID:39886-1738022400-1738281599@www.pharmajournalist.com
SUMMARY:6th RNAi-Based Therapeutics Summit
DESCRIPTION:RNAi Therapeutics holds more promise than ever in treating many diseases beyond the liver\, with momentum in this field growing stronger than ever. Breakthrough companies such as Argonaute RNA and Kate Therapeutics have secured funding to propel their innovative RNAi candidates and delivery platforms\, as well as pharma giants partnering with innovative biotech companies to advance RNAi candidates into the clinic. \n \nThe 6th RNAi-Based Therapeutics Summit is returning to Boston to showcase the latest delivery technologies\, data from clinically successful extra-hepatic targeting\, cutting-edge AI tools to assist payload design\, and breakthrough chemical modifications that enhance stability\, allowing for precise therapeutic delivery. \nUniting 70+ leaders of the RNAi world\, this Summit will empower experts to pioneer their RNAi candidates into clinically successful therapies. Bringing together technical and strategic experts from Novo Nordisk\, Alynlam\, Switch Therapeutics\, Aro Biotherapeutics\, Novartis\, Comanche Biopharma\, and more\, this meeting is a unique gathering of RNAi’s sharpest minds\, dedicated to progressing the next wave of RNAi therapeutics to improve healthcare for patients in need. \nWant to learn more? Download our official brochure here: https://ter.li/00r79n
URL:http://www.pharmajournalist.com/event/6th-rnai-based-therapeutics-summit/
LOCATION:W Boston\, 100 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250131
DTSTAMP:20260515T121520
CREATED:20241031T112719Z
LAST-MODIFIED:20241031T112719Z
UID:39999-1738022400-1738281599@www.pharmajournalist.com
SUMMARY:3rd Molecular Glue Drug Development Summit
DESCRIPTION:The 3rd Molecular Glue Drug Development Summit is returning to bring together leaders across biopharma covering the depth and breadth of the molecular glue field from rational discovery to improving toxicity\, PKPD\, and late-stage development. Don’t miss out on the unparallel learning and networking opportunities on offer at this summit and join 90+ pioneering Directors\, Vice Presidents\, and Heads of Medicinal Chemistry\, Structural Biology\, and Drug Discovery to kickstart your 2025 R&D and fast-track your glues to patients in need faster. \nTo know more visit: https://ter.li/rwb5uq
URL:http://www.pharmajournalist.com/event/3rd-molecular-glue-drug-development-summit/
LOCATION:The Royal Sonesta Boston\, 40 Edwin H Land Blvd\, Cambridge\, MA\, 02142\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250128
DTEND;VALUE=DATE:20250131
DTSTAMP:20260515T121520
CREATED:20241127T123357Z
LAST-MODIFIED:20241127T123357Z
UID:40145-1738022400-1738281599@www.pharmajournalist.com
SUMMARY:3rd Ophthalmic Drug Delivery Summit
DESCRIPTION:Fresh from the reapproval of Roche/Genentech’s Susvimo\, positive readouts for sustained release implants\, and suprachoroidal delivery revolutionizing gene therapy delivery to the retina\, matching the right delivery route to the right drug has become an unavoidable topic for ophthalmology biopharma. \nThe 3rd Ophthalmic Drug Delivery Summit is the premier gathering for the industry to discuss and explore innovations and future directions for ophthalmic device and formulation development. Delve into the latest in-depth analysis of intravitreal\, subretinal\, suprachoroidal and topical delivery and explore advancements in ophthalmic pharmacology. \nWith an ever-growing market opportunity\, the industry is in an arms race to demonstrate the clinical benefits of longer lasting efficacy and less invasive drug delivery through alternative administration routes and novel ocular devices. Reuniting 60+ ophthalmic delivery innovators in sunny San Francisco\, the 3rd Ophthalmic Drug Delivery Summit is the only industry-focused meeting dedicated to translating more efficacious\, longer lasting\, and less invasive retinal delivery. Across 3 jam-packed days\, join clinical and preclinical ocular experts\, ophthalmic device engineers\, product development leaders and formulation specialists to delve a range of ocular drug-delivery systems striving to maintain drug concentrations\, reduce dosage frequency\, and overcome ocular barriers. \nThis meeting is your one-stop-shop to gather key updates on cutting-edge technologies\, ophthalmic pharmacology and to compare routes of administration capabilities to overcome anatomical barriers\, enhance bioavailability\, and improve patient outcomes such as: \n\nOptimizing sustained release formulations and release kinetics to fine-tune dosing for long-lasting retinal delivery with Genentech\, Ocular and Alcon\nEvaluating the durability and safety of delivering drugs to the retina via suprachoroidal delivery with Everads\, Genentech and Clearside\nUtilizing gene therapy transduction via sub retinal and para retinal delivery to the retina with REGENXBIO\, GelMEDIX and Ray Therapeutics\nTroubleshooting species differences and biocompatibility with ocular models to accelerate delivery translation with Genentech and Wake Forest University\nOvercoming clinical trial hurdles and achieving operational synergies to streamline development with Aviceda\, AbbVie and Regeneron\n\nDon’t miss this exclusive opportunity to meet world class ophthalmic delivery experts from the likes of Genentech\, AbbVie\, Bayer\, Clearside Biomedical\, Ocular Therapeutix\, REGENXBIO\, Regeneron\, Eyepoint Pharmaceuticals\, and more.
URL:http://www.pharmajournalist.com/event/3rd-ophthalmic-drug-delivery-summit/
LOCATION:The Clift Royal Sonesta San Francisco\, 495 Geary St\, San Francisco\, CA\, 94102\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR